Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 61 (1), 185-191
- https://doi.org/10.1016/j.ijrobp.2004.04.061
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The role of chemotherapy in brain metastasesEuropean Journal of Cancer, 2003
- Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working GroupZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant TemozolomideJournal of Clinical Oncology, 2002
- Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastasesInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastasesInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?International Journal of Radiation Oncology*Biology*Physics, 2000
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology*Biology*Physics, 1997
- In vitro evaluation of temozolomide combined with X-irradiationAnti-Cancer Drugs, 1997
- Relation between local result and total dose of radiotherapy for brain metastasesInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Radation therapy for brain metastasesAnnals of Neurology, 1980